Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. BB Biotech AG
  6. News
  7. Press Releases
    BION   CH0038389992

BB BIOTECH AG

(BION)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société BB BIOTECH AG
10/22BB BIOTECH : increases positions in oncology and CNS
PU
10/22BB BIOTECH : publishes its interim report
EQ
10/22BB BIOTECH : Gains realized following COVID-19 vaccine booster update enable increases in ..
EQ
07/23BB BIOTECH : Interim report as at June 30, 2021
PU
07/23BB BIOTECH : publishes its interim report
EQ
07/23BB BIOTECH : Solid second quarter for the biotech industry - BB Biotech raised its allocat..
EQ
05/28BB BIOTECH : investment trust review highlights long t...
PU
04/25BB BIOTECH : Sector re-valuation used for portfolio investments
PU
04/25BB BIOTECH : Interim report as at March 31, 2021
PU
04/25BB BIOTECH : publishes interim report
PU
04/23BB BIOTECH : publishes its interim report
EQ
04/23BB BIOTECH AG : Successful vaccination campaigns point the way out of the corona crisis - ..
EQ
04/12BB BIOTECH : Now is an exciting time to have a diverse biot...
PU
03/18BB BIOTECH : Shareholders at BB Biotech AG's AGM vote in favor of all proposals and approv..
PU
03/18BB BIOTECH : Shareholders at BB Biotech AG's AGM vote in favor of all proposals and approv..
EQ
02/19BB BIOTECH : publishes its 2020 annual report
EQ
01/22BB BIOTECH : closes the 2020 fiscal year with a profit
EQ
01/22BB BIOTECH AG : Vaccines leading the way out of the pandemic - increased dividend of CHF 3..
EQ
2020BB BIOTECH : publishes its interim report
EQ
2020BIOTECH M&A PICKS UP IN THE THIRD QU :
EQ
2020BB BIOTECH AG : Innovative biotech companies lead efforts in global challenge
EQ
2020BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
2020BB BIOTECH : publishes its interim report
EQ
2020BB BIOTECH AG : Resilient biotech sector despite widespread market turmoil
EQ
2020BB BIOTECH : Shareholders at BB Biotech AG's AGM vote in favor of all proposals and approv..
EQ
2020BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
2020BB BIOTECH : publishes its 2019 annual report
EQ
2020BB BIOTECH : closes the 2019 fiscal year with a profit
EQ
2020BB BIOTECH : benefits from M&A transactions - dividend of CHF 3.40 proposed
EQ
2019BB BIOTECH : publishes its interim report
EQ
2019BB BIOTECH AG : Political factors weigh on biotech equity markets
EQ
2019BB BIOTECH : publishes its interim report
EQ
2019BB BIOTECH AG : Consolidation leaves a mark on results in the second quarter
EQ
2019BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
2019BB BIOTECH AG : Focus on long-term innovation leads to a strong first quarter of 2019
EQ
2019BB BIOTECH : reports results
EQ
2019BB BIOTECH : concludes its share buyback program and launches a new buyback program
EQ
2019BB BIOTECH AG : Shareholders at the general meeting vote in favor of all proposals and app..
EQ
2019BB BIOTECH : publishes its 2018 annual report
EQ
2019BB BIOTECH : invests gains of M&A transactions in new technologies - dividend of CHF 3.05 ..
EQ
2019BB BIOTECH : closes the 2018 fiscal year with a loss
EQ
2018BB BIOTECH : enlarges its Board of Directors
EQ
2018BB BIOTECH AG : Investors showed renewed interest in biotech stocks during the third quart..
EQ
2018BB BIOTECH : reports preliminary results
EQ
2018BB BIOTECH : shares hold steady in the second quarter
EQ
2018BB BIOTECH : reports preliminary results for 1H 2018
EQ
2018BB BIOTECH : admitted to the SMIM and SPI Index
EQ
2018BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
2018BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
2018BB BIOTECH : share gains value in first quarter 2018 - several large-cap biotech companies..
EQ
2018BB BIOTECH AG : Shareholders at the general meeting vote in favor of all proposals and app..
EQ
2018BB BIOTECH : publishes its 2017 annual report
EQ
2018BB BIOTECH : shows a double-digit total return for 2017 - mid caps overdeliver on innovati..
EQ
2017BB BIOTECH : statement on MiFID II
EQ
2017BB BIOTECH AG : Product approvals and solid company results lead the biotech sector higher
EQ
2016BB BIOTECH : Biotech stocks continue to advance
GL
2016BB BIOTECH AG : BB Biotech AG with profit in the third quarter 2016
GL
2016BB BIOTECH : Stabilization of biotech sector in the second quarter of 2016
GL
2016BB BIOTECH AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act..
GL
2016BB BIOTECH AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with..
GL
2016BB BIOTECH : AG with after-tax loss in the first half year of 2016
GL
2016BB BIOTECH AG : Release of the Home Member State according to Article 2c of the WpHG (the ..
GL
2016BB BIOTECH AG : Challenging first quarter for biotech investments
GL
2016BB BIOTECH : AG with after-tax loss in the first quarter of 2016
GL
2016BB BIOTECH : AG: Shareholders at the general meeting vote in favor of all proposals and ap..
GL
2016BB BIOTECH : AG completed its current share buyback program
GL
2016BB BIOTECH : AG: Outlook for the biotech sector remains positive despite sell-off
GL
2016BB BIOTECH : Director's Dealings announcement according to §15a WpHG (the German Securitie..
GL
2016BB BIOTECH : AG : Fourth quarter returns positive, albeit volatile year in biotech investi..
GL
2016BB BIOTECH : AG earns after-tax profits of CHF 653 million in fiscal 2015
GL
2015BB BIOTECH : Third quarter marked by volatile markets and increasingly nervous biotech inv..
GL
2015BB BIOTECH : AG earns after-tax profits of CHF 141 million as of September 30, 2015
GL
2015BB BIOTECH : AG: Biotech sector weathers the market consolidation
GL
2015BB BIOTECH : AG earns after-tax profits of CHF 717 million in the first half-year 2015
GL
2015BB BIOTECH : Change in TecDax
GL
1  2Next
Upcoming event on BB BIOTECH AG
Upcoming sector events